FRANKLIN LAKES, N.J.,
Jan. 21, 2019 /PRNewswire/ -- The
Board of Directors of BD (Becton, Dickinson and Company) (NYSE:
BDX) has declared a quarterly dividend of $0.77 per common share, payable on March 29, 2019 to holders of record on
March 8, 2019. The indicated
annual dividend rate is $3.08 per
share. In addition, the Board of Directors has declared a
quarterly dividend of $15.3125 per
share on the 6.125% mandatory convertible preferred stock, Series
A, payable on May 1, 2019 to holders
of record on April 15, 2019.
This represents $0.7656 per
depositary share (NYSE: BDXA).
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
healthcare by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for healthcare providers. BD and its 65,000
employees have a passion and commitment to help enhance the safety
and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to healthcare. In 2017, BD welcomed C. R. Bard and its
products into the BD family. For more information on BD, please
visit bd.com.
Contact:
Kristen Cardillo, Corporate
Communications – 201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-board-declares-dividends-300781789.html
SOURCE BD (Becton, Dickinson and Company)